Gene-based vaccines: recent technical and clinical advances
- 1 May 2006
- journal article
- review article
- Published by Elsevier in Trends in Molecular Medicine
- Vol. 12 (5) , 216-222
- https://doi.org/10.1016/j.molmed.2006.03.007
Abstract
No abstract availableKeywords
This publication has 46 references indexed in Scilit:
- Potent immunogenicity of an HIV-1 gag–pol fusion DNA vaccine delivered by in vivo electroporationVaccine, 2006
- Relative contributions of codon usage, promoter efficiency and leader sequence to the antigen expression and immunogenicity of HIV-1 Env DNA vaccineVaccine, 2005
- Enhanced Potency of Plasmid DNA Microparticle Human Immunodeficiency Virus Vaccines in Rhesus Macaques by Using a Priming-Boosting Regimen with Recombinant ProteinsJournal of Virology, 2005
- A rapid and potent DNA vaccination strategy defined by in vivo monitoring of antigen expressionNature Medicine, 2005
- Electroporation as a “Prime/Boost” Strategy for Naked DNA Vaccination against a Tumor AntigenThe Journal of Immunology, 2005
- Enhancement of antigen acquisition by dendritic cells and MHC class II-restricted epitope presentation to CD4+ T cells using VP22 DNA vaccine vectors that promote intercellular spreading following initial transfectionJournal of Leukocyte Biology, 2005
- VP22 enhances antibody responses from DNA vaccines but not by intercellular spreadVaccine, 2005
- Bovine Herpesvirus 1 VP22 Enhances the Efficacy of a DNA Vaccine in CattleJournal of Virology, 2005
- A cationic lipid-formulated plasmid DNA vaccine confers sustained antibody-mediated protection against aerosolized anthrax sporesProceedings of the National Academy of Sciences, 2004
- Vaccination with a DNA Vaccine Encoding Herpes Simplex Virus Type 1 VP22 Linked to Antigen Generates Long-Term Antigen-Specific CD8-Positive Memory T Cells and Protective ImmunityHuman Gene Therapy, 2004